Adcock Ingram Eyeing 20 Launches Including 18 Generic Products
Company Working With Teva On Some Product Dossiers
Executive Summary
Adcock Ingram enjoyed a rise in sales but a dip in profit during its 2020/21 financial year, as the South African firm laid out plans to launch 20 products during its current financial year ending in June 2022, including 18 generics and one new chemical entity.